Table of Contents
ISRN Neurology
Volume 2014 (2014), Article ID 151572, 8 pages
http://dx.doi.org/10.1155/2014/151572
Review Article

Inflammatory Cytokines and Physical Activity in Multiple Sclerosis

Department of Physiotherapy, Portuguese Red Cross Superior Health School, Avenida de Ceuta, Edifício Urbiceuta, 1300-125 Lisboa, Portugal

Received 16 September 2013; Accepted 5 December 2013; Published 27 January 2014

Academic Editors: P. Annunziata and M. G. Grasso

Copyright © 2014 Margarida Florindo. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. J. Craig, C. A. Young, M. Ennis, G. Baker, and M. Boggild, “A randomised controlled trial comparing rehabilitation against standard therapy in multiple sclerosis patients receiving intravenous steroid treatment,” Journal of Neurology, Neurosurgery and Psychiatry, vol. 74, no. 9, pp. 1225–1230, 2003. View at Publisher · View at Google Scholar · View at Scopus
  2. Z. Golzari, F. Shabkhiz, S. Soudi, M. R. Kordi, and S. M. Hashemi, “Combined exercise training reduces IFN-γ and IL-17 levels in the plasma and the supernatant of peripheral blood mononuclear cells in women with multiple sclerosis,” International Immunopharmacology, vol. 10, no. 11, pp. 1415–1419, 2010. View at Publisher · View at Google Scholar · View at Scopus
  3. M. Naegele, K. Tillack, S. Reinhardt, S. Schippling, R. Martin, and M. Sospedra, “Neutrophils in multiple sclerosis are characterized by a primed phenotype,” Journal of Neuroimmunology, vol. 242, no. 1-2, pp. 60–71, 2012. View at Publisher · View at Google Scholar · View at Scopus
  4. C. J. Caspersen, K. E. Powell, and G. Christenson, “Physical activity, exercise and physical fitness: definitions and distinctions for health-related research,” Public Health Reports, vol. 100, no. 2, pp. 126–131, 1985. View at Google Scholar · View at Scopus
  5. D. V. Maltseva, D. A. Sakharov, E. A. Tonevitsky, H. Northoff, and A. G. Tonevitsky, “Killer cell immunoglobulin-like receptors and exercise,” Exercise Immunology Review, vol. 17, pp. 150–163, 2011. View at Google Scholar · View at Scopus
  6. E. Goldhammera, A. Tanchilevitch, I. Maorb, Y. Beniaminia, U. Rosenscheina, and M. Sagivc, “Exercise training modulates cytokines activity in coronary heart disease patients,” International Journal of Cardiology, vol. 100, no. 1, pp. 93–99, 2005. View at Google Scholar
  7. A. Steensberg, A. D. Toft, H. Bruunsgaard, M. Sandmand, J. Halkjær-Kristensen, and B. K. Pedersen, “Strenuous exercise decreases the percentage of type 1 T cells in the circulation,” Journal of Applied Physiology, vol. 91, no. 4, pp. 1708–1712, 2001. View at Google Scholar · View at Scopus
  8. V. Castellano, D. I. Patel, and L. J. White, “Cytokine responses to acute and chronic exercise in multiple sclerosis,” Journal of Applied Physiology, vol. 104, no. 6, pp. 1697–1702, 2008. View at Publisher · View at Google Scholar · View at Scopus
  9. A. Shumway-Cook and M. Wollacott, Motor Control: Theory and Practical Applications, Lippincott Williams & Wilkins, Baltimore, Md, USA, 2002.
  10. P. Flachenecker, “Autoimmune diseases and rehabilitation,” Autoimmunity Reviews, vol. 11, no. 3, pp. 219–225, 2012. View at Publisher · View at Google Scholar · View at Scopus
  11. B. K. Pedersen and L. Hoffman-Goetz, “Exercise and the immune system: regulation, integration, and adaptation,” Physiological Reviews, vol. 80, no. 3, pp. 1055–1081, 2000. View at Google Scholar · View at Scopus
  12. K.-H. Schulz, S. M. Gold, J. Witte et al., “Impact of aerobic training on immune-endocrine parameters, neurotrophic factors, quality of life and coordinative function in multiple sclerosis,” Journal of the Neurological Sciences, vol. 225, no. 1-2, pp. 11–18, 2004. View at Publisher · View at Google Scholar · View at Scopus
  13. C. Sherrington, R. D. Herbert, C. G. Maher, and A. M. Moseley, “PEDro. A database of randomized trials and systematic reviews in physiotherapy,” Manual Therapy, vol. 5, no. 4, pp. 223–226, 2000. View at Publisher · View at Google Scholar · View at Scopus
  14. C. Heesen, S. M. Gold, S. Hartmann et al., “Endocrine and cytokine responses to standardized physical stress in multiple sclerosis,” Brain, Behavior, and Immunity, vol. 17, no. 6, pp. 473–481, 2003. View at Publisher · View at Google Scholar · View at Scopus
  15. H. E. Ploeger, T. Takken, M. H. G. de Greef, and B. W. Timmons, “The effects of acute and chronic exercise on inflammatory markers in children and adults with a chronic inflammatory disease: a systematic review,” Exercise Immunology Review, vol. 15, pp. 6–41, 2009. View at Google Scholar · View at Scopus
  16. I. Walshe, P. Robson-Ansley, A. St Clair Gibson, C. Lawrence, K. G. Thompson, and L. Ansley, “The reliability of the IL-6, sIL-6R and sgp130 response to a preloaded time trial,” European Journal of Applied Physiology, vol. 110, no. 3, pp. 619–625, 2010. View at Publisher · View at Google Scholar · View at Scopus
  17. M. Robinson, S. R. Gray, M. S. Watson et al., “Plasma IL-6, its soluble receptors and F2-isoprostanes at rest and during exercise in chronic fatigue syndrome,” Scandinavian Journal of Medicine and Science in Sports, vol. 20, no. 2, pp. 282–290, 2010. View at Publisher · View at Google Scholar · View at Scopus
  18. P. Robson-Ansley, E. Cockburn, I. Walshe, E. Stevenson, and M. Nimmo, “The effect of exercise on plasma soluble IL-6 receptor concentration: a dichotomous response,” Exercise Immunology Review, vol. 16, pp. 56–76, 2010. View at Google Scholar · View at Scopus
  19. W. J. Kraemer, G. A. Dudley, P. A. Tesch et al., “The influence of muscle action on the acute growth hormone responce to resistance exercise and short-term detraining,” Growth Hormone and IGF Research, vol. 11, no. 2, pp. 75–83, 2001. View at Publisher · View at Google Scholar · View at Scopus
  20. M. F. Neurath and S. Finotto, “IL-6 signaling in autoimmunity, chronic inflammation and inflammation-associated cancer,” Cytokine and Growth Factor Reviews, vol. 22, no. 2, pp. 83–89, 2011. View at Publisher · View at Google Scholar · View at Scopus
  21. A. M. W. Petersen and B. K. Pedersen, “The anti-inflammatory effect of exercise,” Journal of Applied Physiology, vol. 98, no. 4, pp. 1154–1162, 2005. View at Publisher · View at Google Scholar · View at Scopus
  22. L. J. White, V. Castellano, and S. C. McCoy, “Cytokine responses to resistance training in people with multiple sclerosis,” Journal of Sports Sciences, vol. 24, no. 8, pp. 911–914, 2006. View at Publisher · View at Google Scholar · View at Scopus
  23. A. Ray, M. K. Mann, S. Basu, and B. N. Dittel, “A case for regulatory B cells in controlling the severity of autoimmune-mediated inflammation in experimental autoimmune encephalomyelitis and multiple sclerosis,” Journal of Neuroimmunology, vol. 230, no. 1-2, pp. 1–9, 2011. View at Publisher · View at Google Scholar · View at Scopus
  24. L. Lundy-Ekman, Neurocience: Fundamentals For Rehabilitation, Elsevier, Philadelphia, Pa, USA, 2nd edition, 2002.
  25. J. S. Tzartos, M. A. Friese, M. J. Craner et al., “Interleukin-17 production in central nervous system-infiltrating T cells and glial cells is associated with active disease in multiple sclerosis,” American Journal of Pathology, vol. 172, no. 1, pp. 146–155, 2008. View at Publisher · View at Google Scholar · View at Scopus
  26. R. P. Lisak, J. A. Benjamins, L. Nedelkoska et al., “Secretory products of multiple sclerosis B cells are cytotoxic to oligodendroglia in vitro,” Journal of Neuroimmunology, vol. 246, no. 1-2, pp. 85–95, 2012. View at Publisher · View at Google Scholar · View at Scopus
  27. M.-S. Krystyna, T. Jacek, R. Sebastian et al., “Changes in circulating dendritic cells and B-cells in patients with multiple sclerosis relapse during corticosteroid therapy,” Journal of Neuroimmunology, vol. 207, no. 1-2, pp. 107–110, 2009. View at Publisher · View at Google Scholar · View at Scopus
  28. V. A. Shleptsova, E. V. Trushkin, O. A. Bystryh et al., “Expression of early immune response genes during physical exercise,” Bulletin of Experimental Biology and Medicine, vol. 149, no. 1, pp. 89–92, 2010. View at Publisher · View at Google Scholar · View at Scopus
  29. D. Franciotta, M. Salvetti, F. Lolli, B. Serafini, and F. Aloisi, “B cells and multiple sclerosis,” The Lancet Neurology, vol. 7, no. 9, pp. 852–858, 2008. View at Publisher · View at Google Scholar · View at Scopus
  30. T. Smedal, H. Lygren, K.-M. Myhr et al., “Balance and gait improved in patients with MS after physiotherapy based on the Bobath concept,” Physiotherapy Research International, vol. 11, no. 2, pp. 104–116, 2006. View at Publisher · View at Google Scholar · View at Scopus
  31. T. J. Braley and R. D. Chervin, “Fatigue in multiple sclerosis: mechanisms, evaluation, and treatment,” Sleep, vol. 33, no. 8, pp. 1061–1067, 2010. View at Google Scholar · View at Scopus
  32. M. J. Zwarts, G. Bleijenberg, and B. G. M. van Engelen, “Clinical neurophysiology of fatigue,” Clinical Neurophysiology, vol. 119, no. 1, pp. 2–10, 2008. View at Publisher · View at Google Scholar · View at Scopus
  33. M. Leggate, M. A. Nowell, S. A. Jones, and M. A. Nimmo, “The response of interleukin-6 and soluble interleukin-6 receptor isoforms following intermittent high intensity and continuous moderate intensity cycling,” Cell Stress and Chaperones, vol. 15, no. 6, pp. 827–833, 2010. View at Publisher · View at Google Scholar · View at Scopus
  34. P. Robson-Ansley, M. Barwood, J. Canavan et al., “The effect of repeated endurance exercise on IL-6 and sIL-6R and their relationship with sensations of fatigue at rest,” Cytokine, vol. 45, no. 2, pp. 111–116, 2009. View at Publisher · View at Google Scholar · View at Scopus
  35. G. P. Meares, X. Ma, H. Qin, and E. N. Benveniste, “Regulation of CCL20 expression in astrocytes by IL-6 and IL-17,” Glia, vol. 60, no. 5, pp. 771–781, 2012. View at Publisher · View at Google Scholar · View at Scopus
  36. K. L. Campbell, P. T. Campbell, C. M. Ulrich et al., “No reduction in C-reactive protein following a 12-month randomized controlled trial of exercise in men and women,” Cancer Epidemiology Biomarkers and Prevention, vol. 17, no. 7, pp. 1714–1718, 2008. View at Publisher · View at Google Scholar · View at Scopus
  37. M. Kurtuncu, E. Tuzun, R. Turkoglu et al., “Effect of short-term interferon-beta treatment on cytokines in multiple sclerosis: significant modulation of IL-17 and IL-3,” Cytokine, vol. 59, no. 2, pp. 400–422, 2012. View at Google Scholar
  38. S. E. Broughton, T. R. Hercus, A. F. Lopez, and M. W. Parker, “Cytokine receptor activation at the cell surface,” Current Opinion in Structural Biology, vol. 22, no. 3, pp. 350–359, 2012. View at Publisher · View at Google Scholar · View at Scopus
  39. B. K. Pedersen, “Exercise-induced myokines and their role in chronic diseases,” Brain, Behavior, and Immunity, vol. 25, no. 5, pp. 811–816, 2011. View at Publisher · View at Google Scholar · View at Scopus